The BH3 mimetic S1 induces endoplasmic reticulum stress-associated apoptosis in cisplatin-resistant human ovarian cancer cells although it activates autophagy

Oncology Reports

Volumn 30, Issue 6, 2013, Pages 2677-2684

  Liu, Ning ^a   Xu, Ye ^b   Sun, Ji Tong ^a   Su, Jing ^a   Xiang, Xi Yan ^a   Yi, Hao Wei ^a   Zhang, Zhi Chao ^c   Sun, Lian Kun ^a  

^a Basic Medical College   (China)

^b JILIN MEDICAL COLLEGE   (China)

^c DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Autophagy ovarian cancer; BH3 mimetic; Drug resistance; ER stress

Indexed keywords

BH3 PROTEIN; CASPASE 4; CISPLATIN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CANCER RESISTANCE; CELL ACTIVATION; CELL PROTECTION; CELL STRAIN SKOV3; CELL SURVIVAL; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING;

APOPTOSIS; AUTOPHAGY; BIOMIMETICS; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; ENDOPLASMIC RETICULUM STRESS; FEMALE; HUMANS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84892407050     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2771     Document Type: Article

References (44)

1. Karnak D and Xu L: Chemosensitization of prostate cancer by modulating Bcl-2 family proteins. Curr Drug Targets 11: 699-707, 2010.
2. Gul O, Basaga H and Kutuk O: Apoptotic blocks and chemotherapy resistance: strategies to identify Bcl-2 protein signatures. Brief Funct Genomic Proteomic 7: 27-34, 2008.
3. Liu JR, Opipari AW, Tan L, Jiang Y, Zhang Y, Tang H and Nuñez G: Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res 62: 924-931, 2002.
4. Klymenko T, Brandenburg M, Morrow C, Dive C and Makin G: The novel Bcl-2 inhibitor ABT-737 is more effective in hypoxia and is able to reverse hypoxia-induced drug resistance in neuroblastoma cells. Mol Cancer Ther 10: 2373-2383, 2011.
5. Zhang L, Ming L and Yu J: BH3 mimetics to improve cancer therapy: mechanisms and examples. Drug Resist Updat 10: 207-217, 2007.
6. Kang MH and Reynolds CP: Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 15: 1126-1132, 2009.
7. Premkumar DR, Jane EP, DiDomenico JD, Vukmer NA, Agostino NR and Pollack IF: ABT-737 synergizes with bortezomib to induce apoptosis, mediated by Bid cleavage, Bax activation, and mitochondrial dysfunction in an Akt-dependent context in malignant human glioma cell lines. J Pharmacol Exp Ther 341: 859-872, 2012.
8. Wang X, Olberding KE, White C and Li C: Bcl-2 proteins regulate ER membrane permeability to luminal proteins during ER stress-induced apoptosis. Cell Death Differ 18: 38-47, 2010.
9. Bhavya BC, Indira D, Seervi M, Joseph J, Sobhan PK, Mathew KA, Varghese S and Santhoshkumar TR: Endoplasmic reticulum-targeted Bcl-2 inhibitable mitochondrial fragmentation initiates ER stress-induced cell death. Adv Exp Med Biol 749: 83-95, 2012.
10. Dasmahapatra G, Lembersky D, Rahmani M, Kramer L, Friedberg J, Fisher RI, Dent P and Grant S: Bcl-2 antagonists interact synergistically with bortezomib in DLBCL cells in association with JNK activation and induction of ER stress. Cancer Biol Ther 8: 808-819, 2009.
11. Szegezdi E, Macdonald DC, Ní Chonghaile T, Gupta S and Samali A: Bcl-2 family on guard at the ER. Am J Physiol Cell Physiol 296: C941-C953, 2009.
12. Zhou F, Yang Y and Xing D: Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J 278: 403-413, 2010.
13. Marquez RT and Xu L: Bcl-2: Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. Am J Cancer Res 2: 214-221, 2012.
14. Lian J, Wu X, He F, Karnak D, Tang W, Meng Y, Xiang D, Ji M, Lawrence TS and Xu L: A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum. Cell Death Differ 18: 60-71, 2010.
15. Xu Y, Yu H, Qin H, Kang J, Yu C, Zhong J, Su J, Li H and Sun L: Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells. Cancer Lett 314: 232-243, 2011.
16. Shi YH, Ding ZB, Zhou J, Hui B, Shi GM, Ke AW, Wang XY, Dai Z, Peng YF, Gu CY, Qiu SJ and Fan J: Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy 7: 1159-1172, 2011.
17. Zhang Z, Song T, Zhang T, Gao J, Wu G, An L and Du G: A novel BH3 mimetic S1 potently induces Bax/Bak-dependent apoptosis by targeting both Bcl-2 and Mcl-1. Int J Cancer 128: 1724-1735, 2010.
18. Zhang Z, Wu G, Gao J and Song T: Inclusion complex of a Bcl-2 inhibitor with cyclodextrin: characterization, cellular accumulation, and in vivo antitumor activity. Mol Pharm 7: 1348-1354, 2010.
19. Zhang Z, Wu G, Xie F, Song T and Chang X: 3-Thiomorpholin-8-oxo-8H- acenaphtho[1,2-b]pyrrole-9-carbonitrile (S1) based molecules as potent, dual inhibitors of B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1): structure-based design and structure-activity relationship studies. J Med Chem 54: 1101-1105, 2011.
20. Zhong JT, Xu Y, Yi HW, Su J, Yu HM, Xiang XY, Li XN, Zhang ZC and Sun LK: The BH3 mimetic S1 induces autophagy through ER stress and disruption of Bcl-2/Beclin 1 interaction in human glioma U251 cells. Cancer Lett 323: 180-187, 2012.
21. Muller C, Bandemer J, Vindis C, Camaré C, Mucher E, Guéraud F, Larroque-Cardoso P, Bernis C, Auge N, Salvayre R and Negre-Salvayre A: Protein Disulfide Isomerase Modification and Inhibition potentiates ER stress and apoptosis induced by oxidized low density lipoproteins. Antioxid Redox Signal 18: 731-742, 2013.
22. Lee AS: The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci 26: 504-510, 2001.
23. Miller SD, Greene CM, McLean C, Lawless MW, Taggart CC, O'Neill SJ and McElvaney NG: Tauroursodeoxycholic acid inhibits apoptosis induced by Z alpha-1 antitrypsin via inhibition of bad. Hepatology 46: 496-503, 2007.
24. Zhang JY, Diao YF, Kim HR and Jin DI: Inhibition of endoplasmic reticulum stress improves mouse embryo development. PLoS One 7: e40433, 2012.
25. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA and Yuan J: Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 403: 98-103, 2000.
26. Binet F, Chiasson S and Girard D: Evidence that endoplasmic reticulum (ER) stress and caspase-4 activation occur in human neutrophils. Biochem Biophys Res Commun 391: 18-23, 2009.
27. Mao ZG, Jiang CC, Yang F, Thorne RF, Hersey P and Zhang XD: TRAIL-induced apoptosis of human melanoma cells involves activation of caspase-4. Apoptosis 15: 1211-1222, 2010.
28. Verfaillie T, Salazar M, Velasco G and Agostinis P: Linking ER stress to autophagy: potential implications for cancer therapy. Int J Cell Biol 2010: 930509, 2010.
29. Eliopoulos AG, Kerr DJ, Herod J, Hodgkins L, Krajewski S, Reed JC and Young LS: The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. Oncogene 11: 1217-1228, 1995.
30. Mano Y, Kikuchi Y, Yamamoto K, Kita T, Hirata J, Tode T, Ishii K and Nagata I: Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer. Eur J Cancer 35: 1214-1219, 1999.
31. van Delft MF and Huang DC: How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res 16: 203-213, 2006.
32. Simonian PL, Grillot DA and Nuñez G: Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death. Blood 90: 1208-1216, 1997.
33. Reed JC, Miyashita T, Takayama S, Wang HG, Sato T, Krajewski S, Aimé-Sempé C, Bodrug S, Kitada S and Hanada M: BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 60: 23-32, 1996.
34. Schönthal AH: Endoplasmic reticulum stress and autophagy as targets for cancer therapy. Cancer Lett 275: 163-169, 2009.
35. Schönthal AH: Pharmacological targeting of endoplasmic reticulum stress signaling in cancer. Biochem Pharmacol 85: 653-666, 2013.
36. Zhang YX, Kong CZ, Wang LH, Li JY, Liu XK, Xu B, Xu CL and Sun YH: Ursolic acid overcomes Bcl-2-mediated resistance to apoptosis in prostate cancer cells involving activation of JNK-induced Bcl-2 phosphorylation and degradation. J Cell Biochem 109: 764-777, 2010.
37. Shimizu S, Konishi A, Nishida Y, Mizuta T, Nishina H, Yamamoto A and Tsujimoto Y: Involvement of JNK in the regulation of autophagic cell death. Oncogene 29: 2070-2082, 2010.
38. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B and Bao JK: Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif 45: 487-498, 2012.
39. Yu H, Su J, Xu Y, Kang J, Li H, Zhang L, Yi H, Xiang X, Liu F and Sun L: p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins. Eur J Cancer 47: 1585-1594, 2011.
40. Sun WL, Chen J, Wang YP and Zheng H: Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development. Autophagy 7: 1035-1044, 2011.
41. Sirichanchuen B, Pengsuparp T and Chanvorachote P: Long-term cisplatin exposure impairs autophagy and causes cisplatin resistance in human lung cancer cells. Mol Cell Biochem 364: 11-18, 2012.
42. Chen N and Karantza V: Autophagy as a therapeutic target in cancer. Cancer Biol Ther 11: 157-168, 2011.
43. Suh DH, Kim MK, Kim HS, Chung HH and Song YS: Unfolded protein response to autophagy as a promising druggable target for anticancer therapy. Ann NY Acad Sci 1271: 20-32, 2012.
44. Zeng R, He J, Peng J, Chen Y, Yi S, Zhao F and Cui G: The time-dependent autophagy protects against apoptosis with possible involvement of Sirt1 protein in multiple myeloma under nutrient depletion. Ann Hematol 91: 407-417, 2011.